Dose-Reduced Apixaban for Secondary Prophylaxis in Severely Obese Patients: A Single Center Analysis
Blood Adv
.
2025 Jul 1:bloodadvances.2025016037.
doi: 10.1182/bloodadvances.2025016037.
Online ahead of print.
Authors
Eliot A Rapoport
1
,
Noelle W Townsend
2
,
Nadine Farhat
2
,
Parth Patel
1
,
Henny H Billett
2
Affiliations
1
Montefiore Medical Center, New York, New York, United States.
2
Montefiore Medical Center/Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, United States.
PMID:
40590870
DOI:
10.1182/bloodadvances.2025016037
No abstract available